Raymond James Financial
FTXH icon

Raymond James Financial’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Raymond James Financial’s Portfolio FTXH Stock Details FTXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$403K Buy
+11,719
New +$400K ﹤0.01% 4492
2025
Q3 		– Sell
-2,225
Closed -$57K – 5622
2025
Q2 		$57K Buy
+2,225
New +$56.3K ﹤0.01% 5138

Other funds holding FTXH

LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
MIM
Marshall Investment Management Littleton, Colorado $208M AUM 30.96% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
AIP
Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return
NP
Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
VCM
Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return

Raymond James Financial's FTXH Position: Q1 2026 in Review

Raymond James Financial opened a new position in First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q1 2026: 11,719 shares worth $403K. The stake represents ﹤0.01% of the portfolio and ranks #4492 among its holdings. This is a return to the name: Raymond James Financial previously reported a position in FTXH as recently as Q2 2025.

Raymond James Financial first reported a position in FTXH in Q2 2025 and has held it in 2 quarters since. 32 funds tracked by Wall St. Rank hold FTXH as of Q1 2026.

  • Raymond James Financial held 11,719 shares of First Trust Nasdaq Pharmaceuticals ETF worth $403K as of Q1 2026.
  • First Trust Nasdaq Pharmaceuticals ETF was a new Raymond James Financial position in Q1 2026.
  • First Trust Nasdaq Pharmaceuticals ETF made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #4492 holding.
  • Raymond James Financial first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q2 2025 and has held it in 2 quarters since.
  • 32 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.